Skip to main content

Advertisement

Log in

Regional Delivery of Model Compounds and 5-Fluorouracil to the Liver by Their Application to the Liver Surface in Rats: Its Implication for Clinical Use

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to examine drug distribution in the liver after drug application to the rat liver surface.

Methods

Phenolsulfonphthalein (PSP) and fluorescein isothiocyanate dextran (MW 4400, FD-4) as model compounds or 5-fluorouracil (5-FU) was applied to the rat liver surface by employing a cylindrical diffusion cell (i.d. 9 mm, 0.64 cm2). Then, blood and the remaining solution in the diffusion cell were collected at selected times, followed by excision of the liver. The excised liver was divided into three sites: the region under the diffusion cell attachment site (site 1), the applied lobe except for site 1 (site 2), and non-applied lobes (site 3).

Results

In the case of i.v. administration, there were no differences in PSP concentrations among the three sites of the rat liver, and the concentrations rapidly decreased. On the other hand, the PSP concentration in site 1 after application to the rat liver surface was considerably higher than in site 2 and site 3. In addition, the area under the curve (AUC) value (AUCsite1), calculated from the PSP concentration profile in site 1, was about 10 times larger than that in site 3. A similar trend of regional delivery advantage by liver surface application was observed in the case of the macromolecule model FD-4, with a marked AUCsite1 of about 5 times larger than the other two sites. Moreover, we clarified that the anticancer drug 5-FU preferentially distributed in site 1 after application to the rat liver surface.

Conclusion

These results demonstrate the possibility of regional delivery of drugs to the liver by application to the liver surface.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Abbreviations

AUC:

area under the curve

FD-4:

fluorescein isothiocyanate dextran (MW 4400)

5-FU:

5-fluorouracil

PSP:

phenolsulfonphthalein

References

  1. K. Nishida N. Sato H. Sasaki J. Nakamura (1994) ArticleTitleAbsorption of organic anions as model drugs following application to rat liver surface in vivo J. Pharm. Pharmacol. 46 867–870 Occurrence Handle7897589

    PubMed  Google Scholar 

  2. K. Nishida N. Sato H. Sasaki J. Nakamura (1995) ArticleTitleMechanism for drug absorption from rat-liver surface membrane: effect of dose and transport inhibitors on the pharmacokinetics of phenol red J. Pharm. Pharmacol. 47 227–231 Occurrence Handle7602486

    PubMed  Google Scholar 

  3. K. Nishida N. Sato H. Sasaki J. Nakamura (1995) ArticleTitleEffect of albumin on the absorption of phenol red, bromphenol blue and bromosulphonphthalein as model drugs from the liver surface membrane in rats Biol. Pharm. Bull. 18 1548–1550 Occurrence Handle8593477

    PubMed  Google Scholar 

  4. K. Nishida N. Sato Y. Nakakoga T. Mukai H. Sasaki J. Nakamura (1997) ArticleTitleEffect of application volume and area on the absorption of phenol red, as a model drug, from the liver surface in rats J. Pharm. Pharmacol. 49 976–980 Occurrence Handle9364405

    PubMed  Google Scholar 

  5. J. Nakamura A. Tsurumaru K. Mera T. Mukai K. Nishida H. Sasaki (1999) ArticleTitleAbsorption of drugs applied to the gastric serosal surface in rats Pharm. Pharmacol. Commun. 5 519–522

    Google Scholar 

  6. K. Nishida Y. Yoshida T. Mukai S. Kawakami T. Sakaeda M. Nakashima H. Sasaki J. Nakamura (2001) ArticleTitleEffect of instillation method on the absorption of phenolsulphonphthalein as a model drug from the liver and small intestinal serosal surface in rats J. Pharm. Pharmacol. 53 1341–1346 Occurrence Handle10.1211/0022357011777837 Occurrence Handle11697541

    Article  PubMed  Google Scholar 

  7. S. Kawakami R. Hirayama K. Shoji R. Kawanami K. Nishida M. Nakashima H. Sasaki T. Sakaeda J. Nakamura (2002) ArticleTitleLiver- and lobe-selective gene transfection following the instillation of plasmid DNA to the liver surface in mice Biochem. Biophys. Res. Commun. 294 46–50 Occurrence Handle10.1016/S0006-291X(02)00432-1 Occurrence Handle12054738

    Article  PubMed  Google Scholar 

  8. R. Hirayama S. Kawakami K. Nishida M. Nakashima H. Sasaki T. Sakaeda J. Nakamura (2003) ArticleTitleDevelopment of the liver- and lobe-selective nonviral gene transfer following the instillation of naked plasmid DNA using catheter on the liver surface in mice Pharm. Res. 20 328–332 Occurrence Handle10.1023/A:1022204127659 Occurrence Handle12636176

    Article  PubMed  Google Scholar 

  9. K. Nishida N. Sato H. Sasaki J. Nakamura (1996) ArticleTitleAbsorption characteristics of dextrans with different molecular weights from the liver surface membrane in rats: implications for targeting to the liver J. Drug Target. 4 141–150 Occurrence Handle8959486

    PubMed  Google Scholar 

  10. J. Nakamura Y. Yoshizaki M. Yasuhara T. Kimura S. Muranishi H. Sezaki (1976) ArticleTitleMechanisms of the absorption of water-soluble dyes from the rat small intestine Chem. Pharm. Bull. 24 683–690 Occurrence Handle7361

    PubMed  Google Scholar 

  11. J. Watanabe Y. Hayashi K. Iwamoto S. Ozeki (1985) ArticleTitleSalivary excretion of 5-fluorouracil. I. Fluctuation of the saliva/plasma concentration ratio and salivary clearance in beagle dogs following bolus intravenous administration Chem. Pharm. Bull. 33 1187–1194 Occurrence Handle4028299

    PubMed  Google Scholar 

  12. Y. Sawai K. Yamaoka T. Ito T. Nakagawa (1997) ArticleTitleSimultaneous evaluation of intestinal absorption and hepatic extraction of 5-fluorouracil using portal-systemic concentration difference by short-period double dosing in a single conscious rat Biol. Pharm. Bull. 20 1313–1316 Occurrence Handle9448112

    PubMed  Google Scholar 

  13. P. M. Calabro-Jones J. E. Byfield J. F. Ward T. R. Sharp (1982) ArticleTitleTime-dose relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro Cancer Res. 42 4413–4420 Occurrence Handle7127282

    PubMed  Google Scholar 

  14. T. A. Phillips A. Howell R. J. Grieve P. G. Welling (1980) ArticleTitlePharmacokinetics of oral and intravenous fluorouracil in humans J. Pharm. Sci. 69 1428–1431 Occurrence Handle7463330

    PubMed  Google Scholar 

  15. R. B. Diasio B. E. Harris (1989) ArticleTitleClinical pharmacology of 5-fluorouracil Clin. Pharmacokinet. 16 215–237 Occurrence Handle2656050

    PubMed  Google Scholar 

Download references

Acknowledgments

We wish to thank Chieko Kaneko, Masayo Shimomura, and Miyuki Horishita for their skilled technical assistance. This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by a Grant-in-Aid from the Uehara Memorial Foundation, by a Grant-in-Aid from the Nakatomi Foundation and by a Grant-in-Aid for Scientific Research from the President of Nagasaki University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koyo Nishida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishida, K., Fujiwara, R., Kodama, Y. et al. Regional Delivery of Model Compounds and 5-Fluorouracil to the Liver by Their Application to the Liver Surface in Rats: Its Implication for Clinical Use. Pharm Res 22, 1331–1337 (2005). https://doi.org/10.1007/s11095-005-5273-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-005-5273-9

Key Words

Navigation